Unichem Laboratories lost 0.84% to Rs 165.95 at 11:48 IST on BSE after two block deals aggregating 3.50 lakh shares were executed on BSE at Rs 165 per share at 10:57 IST.
One block deal was of 3 lakh shares while another deal was of 50,000 shares.
The block deals constitute 0.38% of Unichem Laboratories' equity.
Meanwhile, the S&P BSE Sensex was up 132.62 points or 0.68% at 19,512.39.
On BSE, 3.51 lakh shares were traded in the counter as against average daily volume of 26,726 shares in the past one quarter.
The stock hit a high of Rs 166.80 and a low of Rs 164 so far during the day. The stock had hit a 52-week low of Rs 138 on 7 August 2013. The stock had hit a 52-week high of Rs 216.80 on 10 January 2013.
The stock had outperformed the market over the past one month till 30 September 2013, surging 15.02% compared with the Sensex's 4.08% rise. The scrip had also outperformed the market in the past one quarter, advancing 1.42% as against Sensex's 0.08% fall.
The small-cap pharmaceutical company has equity capital of Rs 18.12 crore. Face value per share is Rs 2.
Unichem Laboratories' net profit rose 8.9% to Rs 36.10 crore on 0.4% decline in net sales to Rs 262.20 crore in Q1 June 2013 over Q1 June 2012.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
Powered by Capital Market - Live News
